AVITA Medical (AVHHL) Receivables (2018 - 2025)

AVITA Medical has reported Receivables for 8 years, with the latest figure at $9.1 million in Q4 2025.

• For the quarter ending Q4 2025, Receivables fell 22.91% year-over-year to $9.1 million; the trailing twelve-month figure through Dec 2025 stood at $9.1 million (down 22.91% YoY), and the FY2025 full-year result was $9.1 million, down 22.91% from the prior year.
• Receivables for Q4 2025 stood at $9.1 million, up from $9.0 million in the prior quarter.
• The five-year high for Receivables was $12.0 million in Q1 2025, with the low at $3.4 million in Q4 2021.
• Historically, Receivables has averaged $7.1 million across 5 years, with a median of $6.7 million in 2023.
• Annual changes were most pronounced in 2021 — Receivables soared 204.4% — and 2022, when it slumped 42.97%.
• AVITA Medical's Receivables stood at $3.4 million in 2021, then climbed by 28.81% to $4.4 million in 2022, then jumped by 73.67% to $7.7 million in 2023, then surged by 53.78% to $11.8 million in 2024, then declined by 22.91% to $9.1 million in 2025.
• The last three Receivables figures came in at $9.1 million (Q4 2025), $9.0 million (Q3 2025), and $11.3 million (Q2 2025), per Business Quant data.